Schirren, R.; Novotny, A.; Oesterlin, C.; Slotta-Huspenina, J.; Friess, H.; Reim, D.
Significance of Lauren Classification in Patients Undergoing Neoadjuvant/Perioperative Chemotherapy for Locally Advanced Gastric or Gastroesophageal Junction Cancers—Analysis from a Large Single Center Cohort in Germany. Cancers 2021, 13, 290.
https://doi.org/10.3390/cancers13020290
AMA Style
Schirren R, Novotny A, Oesterlin C, Slotta-Huspenina J, Friess H, Reim D.
Significance of Lauren Classification in Patients Undergoing Neoadjuvant/Perioperative Chemotherapy for Locally Advanced Gastric or Gastroesophageal Junction Cancers—Analysis from a Large Single Center Cohort in Germany. Cancers. 2021; 13(2):290.
https://doi.org/10.3390/cancers13020290
Chicago/Turabian Style
Schirren, Rebekka, Alexander Novotny, Christian Oesterlin, Julia Slotta-Huspenina, Helmut Friess, and Daniel Reim.
2021. "Significance of Lauren Classification in Patients Undergoing Neoadjuvant/Perioperative Chemotherapy for Locally Advanced Gastric or Gastroesophageal Junction Cancers—Analysis from a Large Single Center Cohort in Germany" Cancers 13, no. 2: 290.
https://doi.org/10.3390/cancers13020290
APA Style
Schirren, R., Novotny, A., Oesterlin, C., Slotta-Huspenina, J., Friess, H., & Reim, D.
(2021). Significance of Lauren Classification in Patients Undergoing Neoadjuvant/Perioperative Chemotherapy for Locally Advanced Gastric or Gastroesophageal Junction Cancers—Analysis from a Large Single Center Cohort in Germany. Cancers, 13(2), 290.
https://doi.org/10.3390/cancers13020290